AML Compliance Set

AML COMPLIANCE SET

This Anti-Money Laundering Compliance Agreement ("Agreement") is entered into as of between Client Name: , with principal address , and Entity Type: Corporation LLC Other (the "Company"); and Service Provider Name: , with principal address , and Entity Type: Corporation LLC Other (the "Provider").

RECITALS

WHEREAS, the Company engages in financial or fiduciary activities subject to applicable anti-money laundering and counter-terrorist financing laws and regulations; and

WHEREAS, the Provider represents that it maintains and will operate an AML program reasonably designed to detect, prevent and report suspicious activity and to comply with applicable law; and

WHEREAS, the parties desire to set forth their respective obligations with respect to customer due diligence, transaction monitoring, reporting, recordkeeping and related audit and cooperation procedures.

NOW, THEREFORE, in consideration of the mutual covenants set forth below, the parties agree as follows:

1. DEFINITIONS

1.1 "AML Program" means written policies, procedures and internal controls designed to ensure compliance with applicable anti-money laundering laws, including customer identification, transaction monitoring, sanctions screening, and suspicious activity reporting.

1.2 "Customer Due Diligence" or "CDD" means the process of identifying and verifying the identity of Customers, beneficial owners and authorized persons, and assessing risk appropriate to the relationship.

1.3 "SAR" means a suspicious activity report or equivalent filing required by applicable law.

2. PROVIDER AML OBLIGATIONS

2.1 The Provider shall maintain and administer an AML Program that: (a) complies with applicable law; (b) establishes customer identification and verification procedures proportionate to risk; (c) implements persistent transaction monitoring and sanctions screening; and (d) documents and retains records necessary to support compliance and any subsequent examinations by competent authorities.

2.2 The Provider shall perform Enhanced Due Diligence for high-risk customers, including politically exposed persons and customers located in jurisdictions with identified AML deficiencies. Enhanced measures shall include, at minimum, obtaining source of funds documentation, ongoing transaction monitoring with heightened thresholds, and senior management approval prior to onboarding.

3. KYC, IDENTIFICATION AND SCREENING

3.1 The Provider shall: (a) verify identity using reliable, independent source documents, data or information; (b) screen customers, beneficial owners and related parties against applicable sanctions, watch lists and negative media on an ongoing basis; and (c) maintain evidence of verification and screening actions sufficient to demonstrate compliance.

3.2 The Provider will reject or block transactions if required by applicable sanctions or if the Provider reasonably suspects criminal activity, and will notify the Company promptly of any such actions.

4. SUSPICIOUS ACTIVITY REPORTING

4.1 The Provider shall file SARs and any equivalent reports required by law and shall notify the Company of any reportable suspicious activity affecting the Company's accounts or customers, except where notice is prohibited by law or regulation.

5. RECORDKEEPING AND AUDIT

5.1 The Provider shall retain records relating to customer identification, transactions, screening, SARs and AML Program documentation for a period of not less than five (5) years following the date of account closure or final transaction, or such longer period as required by law.

5.2 Upon reasonable notice, the Provider shall permit the Company or its designated auditor to review relevant AML records and compliance procedures to the extent permitted by law, subject to confidentiality obligations.

6. TRAINING AND POLICIES

6.1 The Provider shall provide periodic AML training to relevant personnel, tailored to role and risk, and shall document training attendance and content.

7. REPORTING BREACHES AND MATERIAL CHANGES

7.1 The Provider shall notify the Company in writing within two (2) business days of discovery of any material breach of its AML obligations, any regulatory inquiry, or any enforcement action that materially affects the Provider's ability to perform under this Agreement.

8. REPRESENTATIONS AND WARRANTIES

8.1 Each party represents and warrants that it is duly organized, in good standing and has the authority to enter into this Agreement; that its performance will comply with applicable laws; and that no governmental order prevents performance.

9. INDEMNIFICATION

9.1 Each party shall indemnify, defend and hold harmless the other party from and against any claims, losses, fines, penalties and expenses (including reasonable attorneys' fees) arising out of the indemnifying party's breach of this Agreement, negligence, willful misconduct or failure to comply with applicable AML laws.

10. TERM; TERMINATION

10.1 This Agreement shall commence on the Effective Date and continue until terminated by either party upon thirty (30) days' prior written notice. Either party may terminate immediately for cause if the other party materially breaches a representation or obligation under this Agreement and fails to cure within ten (10) business days after written notice.

11. CONFIDENTIALITY

11.1 Each party shall keep confidential information received from the other and shall not disclose such information except as required by law, regulation, or court order. Where disclosure is required, the receiving party shall provide prompt notice to allow the disclosing party an opportunity to seek protective relief.

12. NOTICES

Notices shall be sent to the addresses set forth above or to such other address as either party designates in writing, and shall be effective upon receipt.

13. AMENDMENT; WAIVER; COUNTERPARTS

13.1 This Agreement may be amended only by a written instrument signed by both parties. No waiver of any provision shall be effective unless in writing and signed by the party granting the waiver. This Agreement may be executed in counterparts, each of which shall be deemed an original.

14. GOVERNING LAW; ENTIRE AGREEMENT; SEVERABILITY

14.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the jurisdiction chosen by the parties below in the Governing Law selection without regard to conflict of laws principles.

14.2 Entire Agreement. This Agreement contains the entire understanding of the parties with respect to its subject matter and supersedes all prior agreements and understandings related to AML compliance between the parties.

14.3 Severability. If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.

15. CERTIFICATIONS

By execution below, the Provider certifies that it has implemented and will maintain an AML Program meeting the standards set forth in this Agreement, that it will promptly notify the Company of any material failure to comply with applicable AML laws, and that the statements provided to the Company regarding AML controls are true and complete to the best of the Provider's knowledge.

ADDITIONAL PROVISIONS

The parties may include additional operational procedures or service-level obligations in an annex or statement of work executed by both parties and incorporated herein by reference.

Sign Now